Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease

NCT00796679 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: paricalcitol

Sponsor

The University of Hong Kong

Collaborators

[object Object]